CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹3.91 Cr | ₹14 Cr | ₹14 Cr | ₹13 Cr | ₹3.89 Cr |
What is the latest Contingent Liabilities ratio of CONCORD BIOTECH ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹3.91 Cr |
| Mar2024 | ₹14 Cr |
| Mar2023 | ₹14 Cr |
| Mar2022 | ₹13 Cr |
| Mar2021 | ₹3.89 Cr |
How is Contingent Liabilities of CONCORD BIOTECH Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.91 Cr | -72.67 | |
| Mar2024 | ₹14 Cr | 0.00 | |
| Mar2023 | ₹14 Cr | 7.43 | |
| Mar2022 | ₹13 Cr | 242.57 | |
| Mar2021 | ₹3.89 Cr | - | |
Compare Contingent Liabilities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹12,814.5 Cr | -2.6% | -9.1% | -42.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹393,323.0 Cr | 1.7% | -5.7% | -7.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,825.0 Cr | 0.8% | -6.7% | 3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,349.0 Cr | 0.6% | 4.3% | 24.4% | Stock Analytics | |
| CIPLA | ₹106,048.0 Cr | -4.7% | -12.3% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,494.0 Cr | 6.3% | -2.1% | -4.1% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -2.6% |
-9.1% |
-42.3% |
| SENSEX | -1.7% |
-4.3% |
6.2% |
You may also like the below Video Courses